Skip to main content

Advertisement

SpringerLink
Log in

Incidence of seizure in adult patients with intracranial metastatic disease

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Seizures have considerable impact on a patient’s quality of life. While guidelines have been articulated to direct clinicians in their management of patients with IMD who suffer from seizure, there have been few attempts to identify the seizure rate in IMD and to determine which primary cancers may be associated with an increased seizure incidence. To determine the incidence of seizure in patients with IMD. A systematic review on seizure incidence in patients with IMD from the magnetic resonance imaging (MRI) era was performed. Articles published between January 2000 and July 2014 with thirty or more consecutive adult patients were included in this study. Seizure rate was calculated using a pooled data analysis. Differences between observed and expected seizure rates between primary tumour sites were examined using the Chi square statistic and adjusted standardized residuals. The systematic search produced 18 relevant studies, with a total study population of 2012 patients. 14.6% (n = 294) had seizures. There was a significant association between primary tumour site and seizure rates. The seizure rate in patients with primary melanoma tumours was significantly greater than expected (z = 2.7; p = .006). The seizure rate in patients with primary prostate tumours was significantly lower than expected (z = −2.6; p = .008). Patients with intracranial metastasis are at significant risk for developing seizure, though at a significantly lower incidence than was estimated by studies performed during the CT era. Seizure rates appear to be greater in certain primary tumours, such as melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lassman AB, DeAngelis LM (2003) Brain metastases. Neurol Clin 21(1–23):vii. doi:10.1016/S0733-8619(02)00035-X

    Google Scholar 

  2. Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48–54. doi:10.1007/s11912-011-0203-y

    Article  PubMed  Google Scholar 

  3. Colombino M, Capone M, Lissia A, Cossu A, Rubino C, De Giorgi V et al (2012) BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol 30:2522–2529. doi:10.1200/JCO.2011.41.2452

    Article  PubMed  Google Scholar 

  4. Lin NU, Winer EP (2007) Brain metastases: the HER2 paradigm. Clin Cancer Res 13:1648–1655. doi:10.1158/1078-0432.CCR-06-2478

    Article  CAS  PubMed  Google Scholar 

  5. Palmieri D, Chambers AF, Felding-Habermann B, Huang S, Steeg PS (2007) The biology of metastasis to a sanctuary site. Clin Cancer Res 13:1656–1662. doi:10.1158/1078-0432.CCR-06-2659

    Article  CAS  PubMed  Google Scholar 

  6. Pectasides D, Gaglia A, Arapantoni-Dadioti P, Bobota A, Valavanis C, Kostopoulou V et al (2006) HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy. Anticancer Res 26:647–653

    CAS  PubMed  Google Scholar 

  7. Yau T, Swanton C, Chua S, Sue A, Walsh G, Rostom A et al (2006) Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab. Acta Oncol 45:196–201. doi:10.1080/02841860500486630

    Article  CAS  PubMed  Google Scholar 

  8. Singh G, Rees JH, Sander JW (2007) Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment. J Neurol Neurosurg PS 78:342–349. doi:10.1136/jnnp.2006.106211

    Article  Google Scholar 

  9. Maschio M (2012) Brain tumor-related epilepsy. Curr Neuropharmacol 10:124–133. doi:10.2174/157015912800604470

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wu AS, Trinh VT, Suki D, Graham S, Forman A, Weinberg JS et al (2013) A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 118:873–883. doi:10.3171/2012.12.JNS111970

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan detroit cancer surveillance system. J Clin Oncol 22:2865–2872. doi:10.1200/JCO.2004.12.149

    Article  PubMed  Google Scholar 

  12. Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr (1991) Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. Am J Neuroradiol 12:293–300

    CAS  PubMed  Google Scholar 

  13. Murakami K, Nawano S, Moriyama N, Sekiguchi R, Satake M, Fujimoto H et al (1996) Intracranial metastases of hepatocellular carcinoma: CT and MRI. Neuroradiology 38(Suppl 1):S31–S35. doi:10.1007/BF02278115

    Article  PubMed  Google Scholar 

  14. Schellinger PD, Meinck HM, Thron A (1999) Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 44:275–281. doi:10.1023/A:1006308808769

    Article  CAS  PubMed  Google Scholar 

  15. Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W et al (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 13:674–681. doi:10.1111/j.1468-1331.2006.01506.x

    Article  CAS  PubMed  Google Scholar 

  16. Tremont-Lukats IW, Bobustuc G, Lagos GK, Lolas K, Kyritsis AP, Puduvalli VK (2003) Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience. Cancer 98:363–368. doi:10.1002/cncr.11522

    Article  PubMed  Google Scholar 

  17. Yokoi K, Kamiya N, Matsuguma H, Machida S, Hirose T, Mori K et al (1999) Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest 115:714–719

    Article  CAS  PubMed  Google Scholar 

  18. Goldlust SA, Hsu M, Lassman AB, Panageas KS, Avila EK (2012) Seizure prophylaxis and melanoma brain metastases. J Neurooncol 108:109–114. doi:10.1007/s11060-012-0802-y

    Article  CAS  PubMed  Google Scholar 

  19. Alva NS, Alva S (2000) Brain metastasis from prostate carcinoma. Cancer 89:706–707. doi:10.1002/1097-0142(20000801)89:3<706::AID-CNCR28>3.0.CO;2-A

    Article  CAS  PubMed  Google Scholar 

  20. de Vasconcelos Sobreira Guedes B, da Rocha AJ, Gama HP, da Silva CJ (2011) Dural metastases from prostate carcinoma: a systematic review of the literature apropos of six patients. Eur J Radiol 80:236–240. doi:10.1016/j.ejrad.2010.06.007

    Article  PubMed  Google Scholar 

  21. Kleinschmidt-DeMasters BK (2001) Dural metastases. A retrospective surgical and autopsy series. Arch Pathol Lab Med 125:880–887. doi:10.1043/0003-9985(2001)125<0880:DM>2.0.CO;2

    CAS  PubMed  Google Scholar 

  22. Damiens K, Ayoub JP, Lemieux B, Aubin F, Saliba W, Campeau MP et al (2012) Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution. Curr Oncol 19:254–258. doi:10.3747/co.19.1048

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. Adv Neurol 19:579–592

    CAS  PubMed  Google Scholar 

  24. Salmaggi AM, I. Vittimberga, G. Grimod, G. Rossi, A. Vola, M. Parolin and E. Bonoldi (2014) Clinico-pathological study in 156 patients operated for brain metastases. Neuro-Oncology 16:ii56. doi:10.1093/neuonc/nou174.213

    Article  PubMed Central  Google Scholar 

  25. Kondziolka D, Kalkanis SN, Mehta MP, Ahluwalia M, Loeffler JS (2014) It is time to reevaluate the management of patients with brain metastases. Neurosurgery 75:1–9. doi:10.1227/NEU.0000000000000354

    Article  PubMed  Google Scholar 

  26. Miabi Z (2011) Metastatic brain tumors: a retrospective review in East Azarbyjan (Tabriz). Acta Med Iran 49:115

    PubMed  Google Scholar 

  27. Lynam LM, Lyons MK, Drazkowski JF, Sirven JI et al (2007) Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 109:634–638. doi:10.1016/j.clineuro.2007.05.017

    Article  PubMed  Google Scholar 

  28. Mongan JP, Fadul CE, Cole BF, Zaki BI et al (2009) Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin colorectal cancer 8:100–105. doi:10.3816/CCC.2009.n.016

    Article  CAS  PubMed Central  Google Scholar 

  29. Lee MH, Kong DS, Seol HJ, Nam DH, Lee JI (2013) Risk of seizure and its clinical implication in the patients with cerebral metastasis from lung cancer. Acta neurochir 155:1833–1837. doi:10.1007/s00701-013-1826-6

    Article  PubMed  Google Scholar 

  30. Srikanth SG, Jayakumar PN, Chandrashekar HS (2002) CT features of intracranial metastases of unknown primaries. Neurol India 50:282

    CAS  PubMed  Google Scholar 

  31. Chang L, Chen YL, Kao MC (2004) Intracranial metastasis of hepatocellular carcinoma: review of 45 cases. Surg Neurol 62:172–177. doi:10.1016/j.surneu.2003.10.002

    Article  PubMed  Google Scholar 

  32. Cohen ZR, Suki D, Weinberg JS, Marmor E et al (2004) Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome. J Neurooncol 66:313–325

    Article  PubMed  Google Scholar 

  33. Zacest AC, Besser M, Stevens G, Thompson JF, McCarthy WH, Culjak G (2002) Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 96:552–558. doi:10.3171/jns.2002.96.3.0552

    Article  PubMed  Google Scholar 

  34. Jena A, Taneja S, Talwar V, Sharma JB (2008) Magnetic resonance (MR) patterns of brain metastasis in lung cancer patients: correlation of imaging findings with symptom. J Thorac Oncol 3:140–144. doi:10.1097/JTO.0b013e318161d775

    Article  PubMed  Google Scholar 

  35. Paek SH, Audu PB, Sperling MR, Cho J, Andrews DW (2005) Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 56:1021–1034

    PubMed  Google Scholar 

  36. Raizer JJ, Hwu WJ, Panageas KS, Wilton A et al (2008) Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro oncol 10:199–207. doi:10.1215/15228517-2007-058

    Article  PubMed  PubMed Central  Google Scholar 

  37. Wong J, Hird A, Zhang L, Tsao M et al (2009) Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy. Int J Radiat Oncol Biol Phys 75:1125–1131. doi:10.1016/j.ijrobp.2008.12.013

    Article  PubMed  Google Scholar 

  38. Shahzadi S, Zali A, Mohammadi AM, Abouzari M, Shirani A, Parsa K (2008) Brain metastases in patients with diagnosed versus undiagnosed primary tumor. Neurosciences 13:268–271

    PubMed  Google Scholar 

  39. Pokryszko-Dragan A, Pawlik B, Bilinska M, Wanczyk I, Buczek A, Kwasniak A (2007) Clinical manifestation and prognostic factors of brain metastases with precocious and metachronous presentation. Adv. Clin Exp Med 16:49–55

    Google Scholar 

  40. Hsiao SY, Chen SF, Chang CC, Lin CH et al (2011) Central nervous system involvement in hepatocellular carcinoma: Clinical characteristics and comparison of intracranial and spinal metastatic groups. J Clin Neurosci 18:3640368. doi:10.1016/j.jocn.2010.04.037

    Article  Google Scholar 

  41. Liigant A, Haldre S, Oun A, Linnamägi U, Saar A, Asser T, Kaasik AE (2001) Seizure disorders in patients with brain tumors. Eur Neurol 25:46–51. doi:10.1159/000052089

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Keenan Research Centre, St. Michael’s Hospital, 30 Bond Street, Toronto, ON, M5B 1W8, Canada

    Vivien Chan, Peter Egeto & Sunit Das

  2. Department of Radiation Oncology, Sunnybrook Hospital, Toronto, ON, Canada

    Arjun Sahgal

  3. Faculty of Medicine, Toronto, ON, Canada

    Tom Schweizer

  4. Division of Neurosurgery, Department of Surgery, Toronto, ON, Canada

    Sunit Das

  5. University of Toronto, Toronto, ON, Canada

    Vivien Chan, Arjun Sahgal, Peter Egeto, Tom Schweizer & Sunit Das

Authors
  1. Vivien Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arjun Sahgal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Egeto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tom Schweizer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sunit Das
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunit Das.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chan, V., Sahgal, A., Egeto, P. et al. Incidence of seizure in adult patients with intracranial metastatic disease. J Neurooncol 131, 619–624 (2017). https://doi.org/10.1007/s11060-016-2335-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2335-2

Keywords

Search

Navigation